These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
121 related articles for article (PubMed ID: 9486410)
1. Circulating CD4+CD8+ T lymphocytes in patients with Kawasaki disease. Hirao J; Sugita K Clin Exp Immunol; 1998 Feb; 111(2):397-401. PubMed ID: 9486410 [TBL] [Abstract][Full Text] [Related]
2. Intravenous immunoglobulin treatment responsiveness depends on the degree of CD8+ T cell activation in Kawasaki disease. Ye Q; Gong FQ; Shang SQ; Hu J Clin Immunol; 2016 Oct; 171():25-31. PubMed ID: 27519954 [TBL] [Abstract][Full Text] [Related]
10. [Analysis of changes in percentage of phenotype CD4 + CD45RA + and CD4+ CD45RO + in peripheral blood and effect of immunomodulation in aged male patients with chronic cardiac insufficiency]. Han LN; Lin XM; Li J; Zang CB; Yang LM; Ding GL; Peng J Zhongguo Ying Yong Sheng Li Xue Za Zhi; 2013 Sep; 29(5):416-21. PubMed ID: 24386816 [TBL] [Abstract][Full Text] [Related]
11. Aberrantly decreased levels of NKG2D expression in children with kawasaki disease. Ge X; Li CR; Yang J; Wang GB Scand J Immunol; 2013 May; 77(5):389-97. PubMed ID: 23298273 [TBL] [Abstract][Full Text] [Related]
12. Distribution of naïve (CD45RA+) and memory (CD45RO+) T-cells in HIV-infected Puerto Rican population. Roman M; Rodriguez JW; Pagán NO; Rios-Olivares E; Amill A; Hunter R P R Health Sci J; 2002 Sep; 21(3):195-201. PubMed ID: 12243109 [TBL] [Abstract][Full Text] [Related]
13. Effect of long-term infection with nef-defective attenuated HIV type 1 on CD4+ and CD8+ T lymphocytes: increased CD45RO+CD4+ T lymphocytes and limited activation of CD8+ T lymphocytes. Zaunders JJ; Geczy AF; Dyer WB; McIntyre LB; Cooley MA; Ashton LJ; Raynes-Greenow CH; Learmont J; Cooper DA; Sullivan JS AIDS Res Hum Retroviruses; 1999 Nov; 15(17):1519-27. PubMed ID: 10580402 [TBL] [Abstract][Full Text] [Related]
14. Flow cytometric characterization of human umbilical cord blood lymphocytes: immunophenotypic features. D'Arena G; Musto P; Cascavilla N; Di Giorgio G; Fusilli S; Zendoli F; Carotenuto M Haematologica; 1998 Mar; 83(3):197-203. PubMed ID: 9573672 [TBL] [Abstract][Full Text] [Related]
15. Reduced frequencies of peripheral interferon-gamma-producing CD4+ and CD4- cells during acute Kawasaki disease. Hahn Y; Kim Y; Jo S; Han H Int Arch Allergy Immunol; 2000 Aug; 122(4):293-8. PubMed ID: 10971121 [TBL] [Abstract][Full Text] [Related]
16. CTLA-4 (CD152) expression in peripheral blood T cells in Kawasaki disease. Matsubara T; Anwar R; Fujiwara M; Ichiyama T; Furukawa S Clin Exp Immunol; 2003 Apr; 132(1):169-73. PubMed ID: 12653853 [TBL] [Abstract][Full Text] [Related]
17. Interleukin-35 regulates peripheral T cell activity in patients with Kawasaki disease. Sun M; Xing H Int Immunopharmacol; 2021 Jul; 96():107642. PubMed ID: 33862556 [TBL] [Abstract][Full Text] [Related]
19. Increase in memory (CD4+CD29+ and CD4+CD45RO+) T and naive (CD4+CD45RA+) T-cell subpopulations in smokers. Tanigawa T; Araki S; Nakata A; Kitamura F; Yasumoto M; Sakurai S; Kiuchi T Arch Environ Health; 1998; 53(6):378-83. PubMed ID: 9886155 [TBL] [Abstract][Full Text] [Related]
20. Characterization of CD4+ T helper cells in patients with Kawasaki disease (KD): preferential production of tumour necrosis factor-alpha (TNF-alpha) by V beta 2- or V beta 8- CD4+ T helper cells. Sakaguchi M; Kato H; Nishiyori A; Sagawa K; Itoh K Clin Exp Immunol; 1995 Feb; 99(2):276-82. PubMed ID: 7851022 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]